Register entry
Paratek Pharmaceuticals, Inc.
- Registered sites
- 0
- Drug products
- 3
- Live patents
- 16
- Countries
- 0
- Base
- Unknown
Sites
Facilities
0No registered facilities
This company holds drug listings or approvals but operates no registered establishment of its own, which is normal for an NDA holder that outsources manufacturing.
Exclusivity
Patents
16Unexpired Orange Book patents where this company is the application holder.
| Product | Active ingredient | Expiry |
|---|---|---|
| NUZYRA | OMADACYCLINE TOSYLATE | Mar 2029 |
| NUZYRA | OMADACYCLINE TOSYLATE | Sept 2030 |
| NUZYRA | OMADACYCLINE TOSYLATE | Oct 2030 |
| NUZYRA | OMADACYCLINE TOSYLATE | Mar 2031 |
| NUZYRA | OMADACYCLINE TOSYLATE | Aug 2037 |
| NUZYRA | OMADACYCLINE TOSYLATE | Oct 2037 |
| XHANCE | FLUTICASONE PROPIONATE | Apr 2031 |
| XHANCE | FLUTICASONE PROPIONATE | Feb 2036 |
Catalogue
Marketed products
3Showing 3 of 3.
| Brand | Generic name | Form | Category |
|---|---|---|---|
| NUZYRA | omadacycline | INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION | NDA |
| NUZYRA | omadacycline | TABLET, FILM COATED | NDA |
| XHANCE | fluticasone propionate | SPRAY, METERED | NDA |
Provenance
Facility and operations data from the FDA Drug Establishments Current Registration Site. Product data from the openFDA National Drug Code Directory. Patent and exclusivity data from the FDA Orange Book. Shortage data from the FDA drug shortage database. Contact details the FDA publishes for registered establishments are deliberately not reproduced here. This entry is compiled from public records and has not been claimed by the company.